Dr Garcia-Sanz speaks with ecancer at EHA 23 about the results from a phase I/II trial of treating r/rHL with brentuximab vedotin, along with ESHAP chemo, to improve depth of response ahead of stem cell transplant. He describes the tolerability of the...
Original Article: Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma